Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 12,359 | 10,198 | 7,167 | 6,866 | 5,810 |
| Gross Profit | 12,359 | 10,198 | 7,167 | 6,866 | 5,810 |
| Operating Expenses | 76,711 | 62,405 | 78,384 | 65,761 | 42,558 |
| Operating Income | -64,352 | -52,207 | -71,217 | -58,895 | -36,748 |
| Interest Expense | 837 | 0 | 33 | 0 | 0 |
| Other Income | -349 | -373 | -235 | -139 | -4,091 |
| Pre-tax Income | -65,538 | -52,580 | -71,485 | -59,034 | -40,839 |
| Net Income Continuous | -65,538 | -52,580 | -71,485 | -59,034 | -40,839 |
| Minority Interests | -150 | -189 | -151 | -224 | -114 |
| Net Income | $-65,388 | $-52,391 | $-71,334 | $-58,810 | $-40,725 |
| EPS Basic Total Ops | -1.67 | -1.37 | -1.86 | -1.56 | -1.22 |
| EPS Basic Continuous Ops | -1.68 | -1.38 | -1.86 | -1.57 | -1.22 |
| EPS Diluted Total Ops | -1.67 | -1.37 | -1.86 | -1.56 | -1.22 |
| EPS Diluted Continuous Ops | -1.68 | -1.38 | -1.86 | -1.57 | -1.22 |
| EBITDA(a) | $-63,635 | $-51,606 | $-70,581 | $-58,495 | $-36,516 |